Commercialization efforts will focus on the most recent version of Genialis' platform, which includes tools for RNA-seq analysis and variant discovery.
Sentieon and DNAstack said their partnership is aimed at lowering the cost and improving the accuracy of genomic data analysis in the cloud.
The funding will go toward bringing the BA100 test to clinicians. The test can identify patients most likely to respond to the standard of care chemotherapy treatment.
Bioage Labs now intends to set up an internal laboratory to experiment with different compounds, while building out its team.
The collaboration will place T1D in the field of precision medicine, potentially allowing JDRF to identify factors that potentially lead to T1D.
Researchers developed a gene expression-based classifier for four gastric cancer subtypes and found that some are associated with better outcomes than others.
The Brown University spinout wants to apply its algorithms to help improve personalized cancer treatments.
Precision medicine platform developer 2bPrecise, a subsidiary of Allscripts, will develop and test genomics care protocols with Mayo Clinic.
The researchers used SC3 to uncover subclones within samples from patients with pre-malignant tumors.
The Croatan algorithm uses the random forest machine learning method to evaluate guide RNAs for use in CRISPR knockout experiments.
The New York Times profiles 23andMe's Anne Wojcicki and describes how she bounced back from a bad year.
Fotis Kafatos, the founding president of the European Research Council, has died, according to the Associated Press.
In PLOS this week: genomic analysis of honeybee disease, microRNA profiles of people with lupus nephritis, and more.
The Verge's Angela Chen tried out a gene test for fitness advice, but didn't learn much new information.